Recurrent angina after coronary revascularization: A clinical challenge

European Heart Journal

Volumn 28, Issue 9, 2007, Pages 1057-1065

  Abbate, Antonio ^a   Biondi Zoccai, Giuseppe G L ^b   Agostoni, Pierfrancesco ^c   Lipinski, Michael J ^d   Vetrovec, George W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Angina; Bypass surgery; Percutaneous coronary intervention; Restenosis; Revascularization; Stent

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; EDIFOLIGIDE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE MONONITRATE; LISINOPRIL; LOSARTAN; METOPROLOL; NICORANDIL; NIFEDIPINE; NITRATE; PACLITAXEL; RANOLAZINE; RAPAMYCIN; SIMVASTATIN; TRIMETAZIDINE; VERAPAMIL;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DIAGNOSTIC PROCEDURE; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; SURVIVAL TIME; THORAX PAIN; THROMBOSIS; TREATMENT OUTCOME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; HUMANS; MYOCARDIAL REVASCULARIZATION; RECURRENCE; STENTS;

EID: 34548436572     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl562     Document Type: Review

References (85)

1. Abrams J. Chronic stable angina. N Engl J Med 2005;352: 2524-2552.
2. Vetrovec GW, Watson J, Chaitman B, Cody R, Wenger N. Symptoms persist in patients with chronic angina despite frequent antianginal use and prior revascularization. J Am Coll Cardiol 2004;43(Suppl. II):A281.
3. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E, TIDES investigators. Characteristics of a contemporary population with angina pectoris. Am J Cardiol 1994;74:226-231.
4. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-468.
5. Henderson RA, Pocock SJ, Clayton TC, Knight R, Fox KAA, Julian DG, Chamberlain DA, for the Second Randomised Intervention Treatment of Angina (RITA-2) trial participants. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:1161-1170.
6. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168.
7. Pocock AJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA; for the RITA-2 participants. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. J Am Coll Cardiol 2000;35:907-914.
8. Serruys PW, Ong ATL, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJR, Schonberger JPMA, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F. Five-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005;46:575-581.
9. Hasdai D, Lerman A, Grill DE, Rihal CS, Holmes DR. Medical therapy after successful percutaneous coronary revascularization. Ann Intern Med 1999;130:108-115.
10. Eisenberg MJ, Okrainec K, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R, Tsang J, Huynh T, Sedlis S, Brown DL, Brieger D, Pilote L; for the ROSETTA Investigators. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry. Can J Cardiol 2003;19:1009-1015.
11. Biondi-Zoccai GGL, Abbate A, Agostoni P, Parisi Q, Turri M, Anselmi M, Vassanelli C, Zardini P, Biasucci LM. Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials. Ital Heart J 2003;4:271-280.
12. Al Suwaidi J, Holmes DR, Salam AM, Lennon R, Berger PB. Impact of coronary artery stents on mortality and non-fatal myocardial infarction: meta-analysis of randomized trial comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J 2004;147:815-822.
13. Indolfi C, Pavia M, Angelillo IF. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol 2005;95:1146-1152.
14. Biondi-Zoccai GG, Lotrionte M, Abbate A, Valgimigli M, Testa L, Burzotta F, Crea F, Agostoni P. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients. Int J Cardiol 2007;114:104-105.
15. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061.
16. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006;27:2784-2814.
17. Reis SE, Holubkov R, Smith AJC, Kelsey SF, Sharaf BL, Reichek N, Rogers WJ, Merz CNB, Sopko G, Pepine CJ; for WISE investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001;141:735-741.
18. Johnson BD, Shaw LJ, Buchtal SD, Merz CNB, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM; for the WISE investigators. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease. Circulation 2004;109:2993-2999.
19. Merz CNB, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G; for the WISE Investigators. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE study). J Am Coll Cardiol 2006;47:21S-29S.
20. Kimble LP, McGuire DB, Dunbar SB, Fazio S, De A, Weintraub WS, Strickland OS. Gender differences in pain characteristics of chronic stable angina and perceived physical limitation in patients with coronary artery disease. Pain 2003;101:45-53.
21. Pepine CJ, Kerensky RA, Lambert CR, Smith KM, von Mering GO, Sopko G, Bairey Merz CN. Some thought on the vasculopathy of women with ischaemic heart disease. J Am Coll Cardiol 2006;47:S30-S35.
22. Wenger NK, Chaitman B, Vetrovec GW. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials. Am J Cardiol 2007;99:11-18.
23. Sharaf BL, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CNB; for the WISE study group. Detailed angiographic analysis of women with suspected ischaemic chest pain (pilot phase data from the NHBLI-sponsored women's ischemia syndrome evaluation [WISE] study angiographic core laboratory). Am J Cardiol 2001;87:937-941.
24. Lemos PA, Hoye A, Serruys PW. Recurrent angina after revascularization: an emerging problem for the clinician. Coron Artery Dis 2004;15(Suppl. 1):S11-S15.
25. Pasceri V, Patti G, Maseri A. Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis. Circulation 1997;96:3278-3280.
26. Jeremias A, Kutscher S, Haude M, Heinen D, Holtmann G, Senf W, Erbel R. Non-ischemic chest pain induced by coronary interventions: a prospective study comparing angioplasty and stent implantation. Circulation 1998;98:2656-1658.
27. Joelson JM, Most AS, Williams DO. Angiographic findins when chest pain recurs after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;60:792-795.
28. Van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW; on behalf of the ARTS Investigators. The effect of the completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;39:559-564.
29. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST events with drugeluting stents. J Am Coll Cardiol 2005;45:2088-2093.
30. Biondi-Zoccai GGL, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, Testa L, Sheiban I, Sangiorgi G. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-2674.
31. Corbett SJ, Cosgrave J, Melzi G, Babic R, Biondi-Zoccai GG, Godino C, Morici N, Airoldi F, Michev I, Montorfano M, Sangiorgi GM, Bonizzoni E, Colombo A. Pattern of restenosis after drug-eluting stent implantation: insights from a contemporary and comparative analysis of sirolimusand paclitaxel-eluting. Eur Heart J 2006;27:2330-2337.
32. Cosgrave J, Melzi G, Biondi-Zoccai GGL, Airoldi F, Chieffo A, Sangiorgi GM, Monfortano M, Michev I, Carlino M, Bonizzoni E, Colombo A. Drug-eluting stent restenosis: the pattern predicts the outcome. J Am Coll Cardiol 2006;47:2399-2407.
33. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
34. Barner J, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg 1985;90:668-675.
35. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, Kouchouckos NT-PREVENT IV investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV - a randomized controlled trial. JAMA 2005;294:2495-2497.
36. Smith SC, Feldman TE, Hirshfield JW, Jacobs AK, Kern MJ, King SB III, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO. ACC/AHA/SCAI 2005 Guidelines update for percutaneous coronary intervention. Circulation 2006;113:156-175.
37. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matcher DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2006; Published online ahead of print.
38. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
39. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993;21:612-621.
40. Uren NG, Marraccini P, Gistri R, de Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 1993;22:650-658.
41. Sambuceti G, Marzilli M, Mari A, Marini C, Schluter M, Testa R, Papini M, Marraccini P, Ciriello G, Marzullo P, L'Abbate A. Coronary microcirculatory vasoconstriction is heterogeneously distributed in acutely ischaemic myocardium. Am J Physiol Heart Circ Physiol. 2005;288:H2298-H2305.
42. Marzilli M, Sambuceti G, Fedele S, L'Abbate A. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol 2000;35:327-334.
43. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
44. Buchthal SD, den Hollander JA, Merz CN, Rogers WJ, Pepine CJ, Reichek N, Sharaf BL, Reis S, Kelsey SF, Pohost GM. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000;342:829-835.
45. Kern MJ, Lerman A, Bech J-W, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NHJ, Siebes M, Spaan JAE. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory. Circulation 2006;114:1321-1341.
46. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 2002;39:847-851.
47. Mak KH, Einsenberg MJ, Tsang J, Okrainiec K, Huynh T, Brown DL; for ROSETTA Investigators. Clinical impact of functional testing strategy among stented and non-stented patients: insights from the ROSETTA registry. Int J Cardiol 2004;95:321-327.
48. Eisenberg MJ, Blankenship JC, Huynh T, Azrin M, Pathan A, Sedlis S, Panja M, Starling MR, Beyar R, Azoulay A, Caron J, Pilote L; for the ADORE Investigators. Evaluation of routine functional testing after percutaneous coronary intervention. Am J Cardiol 2004;93:744-747.
49. Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation 2002;106:2026-2034.
50. Gaspar T, Halon DA, Lewis BS, Adawi S, Schliamser JE, Rubinshtein R, Flugelman MY, Peled N. Diagnosis of coronary in-stent restenosis with multidetector row spiral computed tomography. J Am Coll Cardiol 2005;46:1573-1579.
51. Holton AD, Walsh EG, Brott BC, Venugopalan R, Hershey B, Ito Y, Shih A, Koomullil R, Anayiotos AS. Evaluation of in-stent restenosis by magnetic resonance phase-velocity mapping in nickel-titanium stents. J Magn Reson Imaging 2005;22:248-257.
52. Wilke N, Jerosch-Herold M, Wang Y, Huang Y, Christensen BV, Stillman AE, Ugurbil K, McDonald K, Wilson RF. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-384.
53. Elhendy A, Porter TR. Assessment of myocardial perfusion with real-time myocardial contrast echocardiography: methodology and clinical applications. J Nucl Cardiol 2005;12:582-590.
54. Machac J. Cardiac positron emission tomography imaging. Semin Nucl Med 2005;35:17-36.
55. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL. ACC/AHA 2002 Guidelines Update for exercise testing. 2006; www.acc.org (22 February 2006).
56. Versaci F, Gaspardone A, Tomai F, Proietti I, Crea F, Chiariello L, Gioffre PA. Chest pain after coronary artery stent placement. Am J Cardiol 2002;89:500-504.
57. Kaku B, Honin IK, Horita Y, Uno Y, Yamazaki T, Funada A, Ohka T. The incidence of stent-edge spasm after stent implantation in patient with or without vasospastic angina pectoris. Int Heart J 2005;46:23-33.
58. Nissen SE, Nichills SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; for the ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The ASTEROID trial. JAMA 2006;295:1556-1565.
59. Okrainek K, Pilote L, Platt R, Eisenberg MJ. Use of cardiovascular medical therapy among patients undergoing coronary artery bypass graft surgery: results from the ROSETTA-CABG registry. Can J Cardiol 2006;22:841-847.
60. Boden WE, O'rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk W, Knudtson M, Dada M, Casperson P, Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini GB, Berman DS, Weintraub WS; COURAGE trial coprincipal investigators and study coordinators. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE trial). Am Heart J 2006;151:1173-1179.
61. Lee L, Horowitz J, Frenneaux M. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 2004;25:634- 641.
62. Ruzyllo W, Swed H, Sadowski Z, Elikowski W, Grzelak-Szafranska H, Orszulak W, Szymczak K, Winter M. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study. Curr Med Res Opin 2004;20:1447-1454.
63. Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA; Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators: Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 2004;291:309- 316.
64. IONA study group. Effect of Nicorandil on coronary events in patients with stable angina. The Impact Of Nicorandil in Angina (IONA randomized trial. Lancet 2002;359:1269-1275.
65. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease. Circulation 2004;109:1371-1378.
66. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004;90:457-463.
67. Gowda RM, Khan IA, Punukollu G, Vasavada BC, Nair CK. Treatment of refractory angina pectoris. Int J Cardiol 2005;101:1-7.
68. Kim MC, Kini A, Sharma SK. Refractory angina pectoris: mechanisms and therapeutic options. J Am Coll Cardiol 2002;39:923-934.
69. Soran O, Kennard ED, Kfoury AG, Kelsey SF, IEPR investigators. Two-year clinical outcomes after enhanced external counterpulsation (EECP therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from the International EECP patient registry. Am J Cardiol 2006;97:17-20.
70. Hautvast RW, DeJongste MJ, Staal MJ, van Gilst WH, Lie KI. Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. Am Heart J 1998;136:1114-1120.
71. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Papacci F, Visocchi M, Ierardi C, Meglio M, Bellocci F, Crea F. Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' STsegment depression in patients with cardiac syndrome X. Eur Heart J 2005;26:983-989.
72. Allen KB, Dowling RD, Angell WW, Gangahar DM, Fudge TL, Richenbacher W, Selinger SL, Petracek MR, Murphy D. Transmyocardial revascularization: 5-year follow up of a prospective, randomized multicenter trial. Ann Thorac Surg 2004;77:1228-1234.
73. Itescu S, Kocher AA, Schister MD. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function. Heart Fail Rev 2003;8:253-258.
74. Vale PR, Losordo DW, Milliken CE, McDonald M, Gravelin LM, Curry CM, Esakof DD, Maysky M, Symes M, Symes JF, Isner JM. Randomized, singleblind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001;103:2138-2143.
75. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond K, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK. Clinical trials in coronary angiogenesis: issues, problems, consensus. An expert panel summary. Circulation 2000;102:e73-e86.
76. Kastrati A, Mehilli J, von Bekerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A; for ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-171.
77. Holmes DR, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA; for the SISR investigators. Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents. The SISR randomized trial. JAMA 2006;295:1264-1273.
78. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Ereiakes DJ, Kelley L, Popma JJ, Russell ME, TAXUS V ISR Investigators. Paclitaxel-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006;295:1253-1263.
79. Osswald BR. How to overcome difficulties in the evaluation of best possible decision-making in redo-revascularization? Eur Heart J 2006;27:375-376.
80. Savage M, Douglas J, Fischman D, Pepine CJ, King SB III, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-747.
81. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA; on behalf of the FilterWire EX Randomized Evaluation Investigators. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553.
82. Vermeersch P, Agostoni P. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents? J Interv Cardiol. 2005;18:467-473.
83. Price M, Sawhney N, Kao JA, Madrid A, Schatz RA, Teirstein PS. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Interv 2005;65:208-211.
84. Vermeesch P, Agostoni P, Verheye Van der Heuvel P, Convens C, Bruining N, Van den Branden P, Van Lagenhove G. Randomized doubleblind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous grafts. J Am Coll Cardiol 2006;48:2423-2431.
85. Ellis SG, Brener SJ, Deluca S, Tuzcu EM, Raymond RE, Whitlow PL, Topol EJ. Late myocardial ischaemic events after saphenous vein graft intervention-importance of initially 'nonsignificant' vein graft lesions. Am J Cardiol 1997;79:1460-1464.